ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

PA Available

September 12, 1997

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997